1. Home
  2. SLN vs EVI Comparison

SLN vs EVI Comparison

Compare SLN & EVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$7.10

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$18.35

Market Cap

256.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLN
EVI
Founded
1994
1959
Country
United Kingdom
United States
Employees
116
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
236.2M
256.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
SLN
EVI
Price
$7.10
$18.35
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$42.60
$35.00
AVG Volume (30 Days)
426.8K
22.1K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
1.83%
EPS Growth
N/A
32.43
EPS
N/A
0.26
Revenue
N/A
$389,830,000.00
Revenue This Year
N/A
$15.53
Revenue Next Year
N/A
$3.83
P/E Ratio
N/A
$68.29
Revenue Growth
N/A
10.26
52 Week Low
$3.54
$14.99
52 Week High
$8.40
$34.82

Technical Indicators

Market Signals
Indicator
SLN
EVI
Relative Strength Index (RSI) 54.38 29.59
Support Level $5.76 N/A
Resistance Level $7.53 $21.52
Average True Range (ATR) 0.58 1.22
MACD 0.03 -0.44
Stochastic Oscillator 60.25 13.69

Price Performance

Historical Comparison
SLN
EVI

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

Share on Social Networks: